他汀使用与健康老年人无残疾生存及心血管疾病的关联
基于 ASPREE 随机试验中 18,096 名 ≥70 岁健康社区居住老年人的数据,采用逆概率加权 Cox 回归比较基线使用他汀者与未使用者。中位随访 4.7 年,基线他汀使用与无残疾生存、全因死亡或痴呆风险无关联,但与身体残疾和所有心血管结局风险降低相关。
要点
- 健康 ≥70 岁老年人使用他汀未延长无残疾生存或降低死亡/痴呆风险。
- 他汀使用与身体残疾风险及所有心血管结局风险降低相关。
- 尚需未来临床试验证实这些观察性关联。
核心结论
- 在健康社区居住的 ≥70 岁成年人中,他汀使用可能有益于预防身体残疾和心血管疾病,但对延长无残疾生存或避免死亡或痴呆无益。
研究设计与样本
- ASPREE 随机试验纳入澳大利亚和美国 19,114 名 ≥65 岁社区居住者,无 documented CVD、痴呆和残疾;本分析纳入 ≥70 岁者 18,096 名,比较基线使用他汀者与未使用者,采用逆概率加权 Cox 比例风险回归。
主要发现
- 18,096 名参与者中位年龄 74.2 岁,女性占 56.0%,5,629 名基线使用他汀。
- 中位随访 4.7 年,基线他汀使用与无残疾生存、全因死亡风险或痴呆风险无关联。
- 基线他汀使用与身体残疾风险和所有心血管结局风险降低相关。
临床怎么用
- 对 ≥70 岁健康老年人处方他汀时,应权衡其在预防身体残疾和心血管疾病方面的潜在获益与对无残疾生存、死亡和痴呆无显著影响的结果。
局限性
- 本文为基于 ASPREE 试验数据的观察性分析,非随机比较他汀使用,需未来临床试验证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is clinical uncertainty regarding the benefits and harms of prescribing statins in healthy subjects ≥70 years of age. OBJECTIVES: The aim of this study was to examine the association among statins, dementia-free and disability-free survival, and cardiovascular disease (CVD) among healthy older adults using data from the ASPREE (Aspirin in Reducing Events in the Elderly) trial. METHODS: ASPREE was a randomized trial of 19,114 community-dwelling persons in Australia and the United States ≥65 years of age and free of documented CVD, dementia, and disability. Data were collected for those ≥70 years of age, and participants who took statins at baseline were compared with those who did not using Cox proportional hazards regression with inverse probability weighting. The primary outcome, referred to as "disability-free survival," was a composite of all-cause mortality, dementia, or persistent physical disability. Other outcomes included the individual components of the composite outcome, major adverse cardiovascular events, fatal CVD, myocardial infarction, and stroke. RESULTS: Of the 18,096 included participants (median age 74.2 years, 56.0% women), 5,629 took statins at baseline. Over a median follow-up period of 4.7 years, baseline statin use was not associated with disability-free survival or with the risk for all-cause mortality or dementia. However, it was associated with lower risks for physical disability and all cardiovascular outcomes. CONCLUSIONS: Among healthy community-dwelling adults ≥70 years of age, statin use may be beneficial for preventing physical disability and CVD but not beneficial for prolonging disability-free survival or avoiding death or dementia. Future clinical trials are needed to confirm these findings.
引用
- Zhou Z, Ofori-Asenso R, Curtis AJ, et al. Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults. J Am Coll Cardiol. 2020. PMID: 32616158. doi:10.1016/j.jacc.2020.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。